Mangalam Drugs And Organics Limited — Others, 12-08-2025: Shareholders meeting

Mangalam Drugs and Organics convened a meeting with its unsecured creditors to address a significant corporate restructuring. The purpose was to seek approval for a merger plan where Mangalam Drugs will absorb Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited. This strategic move aims to consolidate their business operations. The scheme was put forth for the creditors' consideration and approval. The company announced that the final voting results from this meeting will be disclosed via stock exchanges and its website soon.